Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-dose interstitial brachytherapy for glioblastoma multiforme

E Micheletti1, G Baroncelli, B La Face

  • 1Radiotherapy Department, University-Hospital of Brescia, Italy.

Tumori
|February 28, 1994
PubMed
Summary

High-dose rate brachytherapy offers a short treatment period for glioblastoma multiforme (GBL). This HDR brachytherapy approach showed potential for palliation, with some patients experiencing improved performance status post-treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "MO-11.2 - Explainable artificial intelligence applied to machine learning for radiomics" [Physica Medica 115S1 (2023) 102870].

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2024
Same author

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes.

Clinical Medicine Insights. Oncology·2017
Same author

Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2015
Same author

Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis.

European journal of gynaecological oncology·2014
Same author

Optimisation of an MDCT abdominal protocol: Image quality assessment of standard vs. iterative reconstructions.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2013
Same author

Transcontinental anaesthesia: a pilot study.

British journal of anaesthesia·2013

Area of Science:

  • Neuro-oncology
  • Radiation Oncology

Background:

  • Glioblastoma multiforme (GBL) has a poor long-term survival prognosis.
  • Conventional radiotherapy offers only temporary results for GBL treatment.

Purpose of the Study:

  • To evaluate the therapeutic and psychologic effects of high-dose rate (HDR) brachytherapy for inoperable GBL.
  • To assess the feasibility and outcomes of a novel HDR brachytherapy protocol for GBL palliation.

Main Methods:

  • Five patients with GBL underwent stereotactic biopsy followed by HDR brachytherapy.
  • A single coaxial after-loading catheter was stereotactically placed within the tumor.
  • Treatment involved 5 fractions of 5 Gy/fraction, delivered in 2 sessions per day.

Main Results:

Related Experiment Videos

  • The HDR brachytherapy protocol was well-tolerated by patients.
  • Tumor progression recurred between 8 and 16 weeks post-treatment.
  • Average survival was 21 weeks, with some patients showing initial performance status improvement.

Conclusions:

  • HDR brachytherapy presents a viable option for GBL palliation due to its short treatment duration.
  • Potential improvements include multi-catheter implants and a more fractionated treatment schedule.
  • This approach offers advantages for managing GBL symptoms and improving patient well-being.